SURMODICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.17 USD | 0.00% |
|
-1.21% | -28.01% |
| Feb. 06 | Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating | MT |
| Feb. 01 | Needham Adjusts SurModics' Price Target to $47 From $44, Maintains Buy Rating | MT |
Chart calendar Surmodics, Inc.
280.wszIREW_wOF5Vyc7ZZtsN5bpCgPbp-_7ihFsGY6bOU8.if2jFzXl-KouLRZMJtMhAfmiQWjqy6e-3HMkf_fNb3qOpb91DIn3gxA4VA~40ec45e213fd487cc35f81aa55ec884b
Upcoming events on Surmodics, Inc.
Past events on Surmodics, Inc.
| 2024-04-09 03:00 pm | Needham Healthcare Conference |
| 2024-03-13 02:00 pm | Oppenheimer Healthcare MedTech & Services Conference |
| 2024-02-08 05:00 pm | Annual General Meeting |
| 2024-02-01 08:00 am | Q1 2024 Earnings Call |
| 2024-02-01 07:00 am | Q1 2024 Earnings Release |
| 2023-11-28 08:30 am | Piper Sandler Healthcare Conference |
| 2023-11-15 09:18 am | VEITH Symposium |
| 2023-11-08 08:00 am | Q4 2023 Earnings Call |
| 2023-11-08 07:30 am | Q4 2023 Earnings Release |
| 2023-08-16 10:45 am | Sidoti Micro Cap Conference |
| 2023-08-13 | Needham Virtual MedTech & Diagnostics Conference |
| 2023-08-02 08:00 am | Q3 2023 Earnings Call |
| 2023-08-02 07:31 am | Q3 2023 Earnings Release |
| 2023-06-08 01:30 pm | Jefferies Global Healthcare Conference |
| 2023-04-26 08:00 am | Q2 2023 Earnings Call |
| 2023-04-26 07:00 am | Q2 2023 Earnings Release |
| 2023-04-20 10:15 am | Needham Virtual Healthcare Conference |
| 2023-03-21 | Sidoti Spring Small-Cap Conference |
| 2023-03-15 10:40 am | Oppenheimer Healthcare Conference |
| 2023-02-09 05:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 100 97,6 2.53% | 94,9 93,1 1.92% | 105 104 0.95% | 100,0 98,0 1.94% | 133 131 1.3% | 120 |
|
EBITDA Million USD | Released Forecast Spread | 14,1 13,1 7.84% | 5,77 5,75 0.26% | 12,0 10,9 10.8% | -12,9 -14,9 13.45% | 13,9 9,20 50.8% | 4,23 |
|
EBIT Million USD | Released Forecast Spread | 6,47 5,75 12.58% | -1,25 -1,57 20.53% | 6,70 2,90 131.48% | -22,1 -24,5 9.67% | 5,60 1,59 251.84% | -12,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7,56 6,70 12.88% | -1,45 -1,73 15.93% | 6,35 2,60 143.84% | -22,5 -24,7 8.84% | 2,49 -1,61 254.26% | -15,6 |
|
Net income Million USD | Released Forecast Spread | 7,59 7,50 1.24% | 1,12 1,93 -41.93% | 4,24 0,46 820.09% | -27,3 -19,9 -36.91% | -1,54 -6,37 75.87% | -16,1 |
|
EPS USD | Released Forecast Spread | 0,55 0,55 0.92% | 0,08 0,14 -42.86% | 0,30 0,04 757.14% | -1,96 -1,44 -36.59% | -0,11 -0,45 75.56% | -1,17 |
| Announcement Date | 31/10/19 | 04/11/20 | 10/11/21 | 09/11/22 | 08/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 23,0 23,7 -2.97% | 26,1 24,0 8.89% | 24,9 25,2 -1.35% | 26,0 24,1 7.87% | 24,9 24,0 4.03% | 27,2 25,9 5.18% | 52,5 38,1 37.88% | 28,0 26,3 6.46% | 30,6 29,6 3.06% | 28,8 | 29,9 | 30,4 | 33,5 | 34,1 |
|
EBITDA Million USD | Released Forecast Spread | -1,03 -3,35 69.19% | -2,58 -4,15 37.88% | -4,85 -4,60 -5.48% | -4,39 -6,40 31.41% | -5,23 -6,90 24.17% | -3,28 -4,45 26.2% | 23,5 18,2 29.13% | -0,28 -4,50 93.71% | 1,97 0,45 337.21% | 0,03 | 0,02 | 0,20 | 3,47 | 5,26 |
|
EBIT Million USD | Released Forecast Spread | -3,44 -5,92 41.83% | -4,90 -6,92 29.15% | -7,14 -7,52 4.99% | -6,61 -8,97 26.29% | -7,23 -9,28 22.06% | -5,30 -7,82 32.2% | 21,4 1,38 1453.47% | -2,45 -6,01 59.22% | -0,32 -3,79 91.51% | -4,36 | -3,90 | -3,85 | 0,14 | 1,33 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,52 -5,94 40.77% | -5,00 -6,94 27.94% | -7,18 -7,54 4.82% | -6,79 -8,97 24.3% | -8,01 -10,1 20.56% | -7,37 -8,64 14.72% | 20,6 0,52 3870.96% | -2,79 -6,88 59.43% | -0,72 -4,49 83.89% | -5,26 | -4,84 | -4,80 | -0,22 | 0,99 |
|
Net income Million USD | Released Forecast Spread | -2,81 -5,00 43.72% | -4,08 -5,85 30.24% | -5,65 -6,33 10.67% | -14,7 -7,37 -99.74% | -7,84 -10,0 21.8% | -7,73 -8,52 9.25% | 7,35 0,15 4690.97% | 6,69 1,88 257.01% | -0,79 -5,13 84.69% | -5,71 | -4,86 | -4,71 | -0,08 | 1,01 |
|
EPS USD | Released Forecast Spread | -0,20 -0,36 44.83% | -0,29 -0,43 31.76% | -0,41 -0,46 10.38% | -1,06 -0,53 -99.06% | -0,56 -0,72 21.68% | -0,55 -0,61 9.47% | 0,52 -0,50 204% | 0,47 0,13 254.72% | -0,06 -0,36 83.45% | -0,40 | -0,37 | -0,36 | -0,01 | 0,08 |
| Announcement Date | 03/02/22 | 27/04/22 | 27/07/22 | 09/11/22 | 06/02/23 | 26/04/23 | 02/08/23 | 08/11/23 | 01/02/24 | - | - | - | - | - |
More events
Past sector events for Surmodics, Inc.
| 2024-04-26 | BLUE SAIL MEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-26 | BLUE SAIL MEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-26 06:00 am | AVANTOR, INC.: Q1 2024 Earnings Release |
| 2024-04-25 | MOTIC (XIAMEN) ELECTRIC GROUP CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 | MICRO-TECH (NANJING) CO.,LTD: Q1 2024 Earnings Release |
| 2024-04-25 | SINOCARE INC.: Q4 2023 Earnings Release |
| 2024-04-25 | JAFRON BIOMEDICAL CO.,LTD.: Q1 2024 Earnings Release |
| 2024-04-25 | MICRO-TECH (NANJING) CO.,LTD: Q4 2023 Earnings Release |
| 2024-04-25 | JAFRON BIOMEDICAL CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | SINOCARE INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SRDX Stock
- Calendar Surmodics, Inc.
